JP2004059440A - 肌荒れ防止および粘膜修復剤 - Google Patents
肌荒れ防止および粘膜修復剤 Download PDFInfo
- Publication number
- JP2004059440A JP2004059440A JP2002216119A JP2002216119A JP2004059440A JP 2004059440 A JP2004059440 A JP 2004059440A JP 2002216119 A JP2002216119 A JP 2002216119A JP 2002216119 A JP2002216119 A JP 2002216119A JP 2004059440 A JP2004059440 A JP 2004059440A
- Authority
- JP
- Japan
- Prior art keywords
- skin
- preventing
- agent
- repairing
- rough skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000007788 roughening Methods 0.000 title abstract description 10
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 30
- 206010013786 Dry skin Diseases 0.000 claims abstract description 20
- 230000006378 damage Effects 0.000 claims abstract description 9
- 239000001814 pectin Substances 0.000 claims abstract description 9
- 235000010987 pectin Nutrition 0.000 claims abstract description 9
- 229920001277 pectin Polymers 0.000 claims abstract description 9
- 210000004877 mucosa Anatomy 0.000 claims abstract description 7
- 230000037336 dry skin Effects 0.000 claims abstract description 6
- 239000004480 active ingredient Substances 0.000 claims abstract description 5
- 201000004624 Dermatitis Diseases 0.000 claims abstract description 4
- 230000000172 allergic effect Effects 0.000 claims abstract description 4
- 210000004400 mucous membrane Anatomy 0.000 claims description 33
- 238000002360 preparation method Methods 0.000 claims description 12
- 239000002552 dosage form Substances 0.000 claims description 7
- 239000007787 solid Substances 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 3
- 210000002200 mouth mucosa Anatomy 0.000 claims description 3
- 206010022998 Irritability Diseases 0.000 claims 1
- 208000026935 allergic disease Diseases 0.000 claims 1
- 210000004347 intestinal mucosa Anatomy 0.000 claims 1
- 210000002850 nasal mucosa Anatomy 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 14
- 208000017520 skin disease Diseases 0.000 abstract description 8
- 230000003628 erosive effect Effects 0.000 abstract description 5
- 206010012438 Dermatitis atopic Diseases 0.000 abstract description 3
- 206010012442 Dermatitis contact Diseases 0.000 abstract description 3
- 201000004681 Psoriasis Diseases 0.000 abstract description 3
- 201000008937 atopic dermatitis Diseases 0.000 abstract description 3
- 208000010668 atopic eczema Diseases 0.000 abstract description 3
- 208000010247 contact dermatitis Diseases 0.000 abstract description 3
- 208000024891 symptom Diseases 0.000 abstract description 3
- 208000010201 Exanthema Diseases 0.000 abstract description 2
- 201000005884 exanthem Diseases 0.000 abstract description 2
- 206010037844 rash Diseases 0.000 abstract description 2
- 208000010445 Chilblains Diseases 0.000 abstract 1
- 206010008528 Chillblains Diseases 0.000 abstract 1
- 210000000214 mouth Anatomy 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- -1 etc. Substances 0.000 description 7
- 230000003449 preventive effect Effects 0.000 description 6
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 239000002674 ointment Substances 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 3
- 230000036572 transepidermal water loss Effects 0.000 description 3
- 241000700199 Cavia porcellus Species 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 102000011782 Keratins Human genes 0.000 description 2
- 108010076876 Keratins Proteins 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 229940124599 anti-inflammatory drug Drugs 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 2
- 230000036407 pain Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 208000001034 Frostbite Diseases 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000978776 Senegalia senegal Species 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000008311 hydrophilic ointment Substances 0.000 description 1
- 229920001477 hydrophilic polymer Polymers 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000005722 itchiness Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002216119A JP2004059440A (ja) | 2002-07-25 | 2002-07-25 | 肌荒れ防止および粘膜修復剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002216119A JP2004059440A (ja) | 2002-07-25 | 2002-07-25 | 肌荒れ防止および粘膜修復剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004059440A true JP2004059440A (ja) | 2004-02-26 |
| JP2004059440A5 JP2004059440A5 (enExample) | 2005-10-27 |
Family
ID=31937960
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002216119A Pending JP2004059440A (ja) | 2002-07-25 | 2002-07-25 | 肌荒れ防止および粘膜修復剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2004059440A (enExample) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004100966A1 (ja) * | 2003-05-16 | 2004-11-25 | Bbk Bio Corporation | 病態起因物質の生体への接触防止用製剤 |
| WO2011063774A2 (en) | 2009-11-25 | 2011-06-03 | Zentiva, K.S. | Pectin complexes of steroids and pharmaceutical compositions based thereon |
-
2002
- 2002-07-25 JP JP2002216119A patent/JP2004059440A/ja active Pending
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004100966A1 (ja) * | 2003-05-16 | 2004-11-25 | Bbk Bio Corporation | 病態起因物質の生体への接触防止用製剤 |
| US8802641B2 (en) | 2003-05-16 | 2014-08-12 | Natura Corporation | Method for inhibiting onset of or treating pollen allergy |
| US9433637B2 (en) | 2003-05-16 | 2016-09-06 | Kobayashi Pharmaceutical Co., Ltd. | Method for inhibiting influenza virus infection |
| WO2011063774A2 (en) | 2009-11-25 | 2011-06-03 | Zentiva, K.S. | Pectin complexes of steroids and pharmaceutical compositions based thereon |
| WO2011063775A2 (en) | 2009-11-25 | 2011-06-03 | Zentiva, K.S. | Pectin complexes of sartans and pharmaceutical compositions based thereon |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5118633B2 (ja) | 医療用デバイスおよび医薬製剤において有用な粘膜付着性キシログルカン含有製剤 | |
| CA2646667C (en) | Methods of treating hot flashes with formulations for transdermal or transmucosal application | |
| RU2572694C2 (ru) | Композиция кожного препарата для наружного применения | |
| US9050351B2 (en) | Topical compositions designed to maintain or restore the integrity of the mucous membranes | |
| JP2002520281A (ja) | 粘膜疾患の局所治療における使用のためのビタミンｅおよびそのエステル | |
| CN1136919C (zh) | 含有米诺地尔的外用组合物 | |
| WO2006109734A1 (ja) | 創傷治療用外用剤 | |
| HU226065B1 (hu) | Egy diol és egy alfa-hidroxisav keverékének alkalmazása hiperkeratózisos bõrbetegségek kezelésére szolgáló gyógyszer elõállítására | |
| JP2004059440A (ja) | 肌荒れ防止および粘膜修復剤 | |
| CN101500550B (zh) | 增强促弹性活性的组合物 | |
| EP1421940A1 (en) | Medical composition for external use for dermatosis | |
| JPH11505238A (ja) | 皮膚症状処置用組成物 | |
| JP2006321778A (ja) | 皮膚修復用組成物及びそれを用いた皮膚修復剤 | |
| TWI862350B (zh) | 治療表皮分解性水疱症的方法 | |
| CA2341566C (fr) | Utilisation du gluconate de lithium dans la fabrication d'un medicament pour le traitement de l'herpes et de la dermite seborrheique | |
| JPH09263529A (ja) | 表皮角質化促進剤 | |
| JP2012530683A (ja) | 皮膚水分透過機能異常の予防又は治療剤 | |
| JP2024508139A (ja) | 乾癬治療のための蛋白質分解酵素混合物 | |
| CN120899927A (zh) | 促进局部组织一氧化氮释放水平增加的组合物及其用途 | |
| JPH10218731A (ja) | 脱毛処理後の皮膚トリートメント外用剤 | |
| WO2012159937A1 (en) | Compositions for the treatment of vaginal or rectal mucositis | |
| JP2005247825A (ja) | 皮膚外用剤及び皮膚乾燥トラブル改善剤 | |
| WO2015032700A1 (en) | Use of trifluoroacetic acid as keratolytic agent to treat hyperkeratotic skin lesions | |
| HK1231396B (zh) | 外用组合物 | |
| JP2009535322A (ja) | 病理的瘢痕の高色素沈着を治療することを意図する、ヒドロキノン、フルオシノロンアセトニド、およびトレチノインの組み合わせを含む皮膚科学組成物の使用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050725 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20050725 |
|
| A131 | Notification of reasons for refusal |
Effective date: 20090324 Free format text: JAPANESE INTERMEDIATE CODE: A131 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20090728 |